Zota Health Care Ltd (ZOTA) is currently trading at 1,232.20 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Zota Health Care Limited manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and OTC products, while operating Davaindia, a private-label generic pharmacy chain. Its model combines domestic distribution, exports from the Sachin SEZ facility, company-owned stores, franchise outlets, and backward integration through Everyday Herbal Group. Davaindia has become the dominant growth engine, with sales rising 76.25% year over year in Q2FY27 and contributing approximately 82% of H1FY27 revenue. The chain reached 2,840 stores, generated quarterly GMV of ₹18,791 lakhs, and recorded customer footfall of 66.17 lakh. The company’s retail economics are attractive at the gross-profit level, with consolidated gross margin reaching 60.17% in Q2FY27 and COCO stores reporting approximately 65% gross margin. However, high employee, operating, depreciation, and lease costs meant consolidated PAT remained negative at ₹2,596.01 lakhs. Management moderated store additions during Q2FY27 to consolidate the expanded network, improve store-level productivity, and strengthen cash generation. Despite this pause, mature COCO stores generated average monthly GMV of ₹8.08 lakhs, while the company plans to accelerate expansion during H2FY27. Zota is transitioning from a traditional pharmaceutical marketer into an integrated healthcare platform. Its 87.78% Everyday Herbal stake supports OTC backward integration, the Curexis acquisition adds the SKIA pharmacy chain, and cloud-based systems, AI-enabled operations, and hyperlocal delivery support retail scalability.

Over the past 52 weeks, Zota Health Care Ltd has traded between a low of ₹1,022.00 and a high of ₹1,740.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Zota Health Care Ltd has a market capitalization of approximately 4,215.13. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Zota Health Care Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -36.97 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 4,215.13 Cr, Zota Health Care Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Zota Health Care Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Zota Health Care Ltd is -36.97. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Zota Health Care reported 92% year-on-year growth in consolidated revenue in Q2FY26.

Zota Health Care reported a consolidated net loss of ₹25.58 crore for the September quarter of FY27, according to the supplied TradingView News headline.